Full Access
Myelin basic protein and creatine kinase BB isoenzyme as CSF markers of intracranial tumors and stroke
J. Matias-Guiu,
J. Martinez-Vazquez,
A. Ruibal,
R. Colomer,
M. Boada,
A. Codina,
Corresponding Author
J. Matias-Guiu
Departments of Neurology, the Autonomous University, Barcelona, Spain
Dr. J. Matias-Guiu, Neurology Service, Hospital del Valle de Hebrón, Barcelona SpainSearch for more papers by this authorJ. Martinez-Vazquez
Departments of Medicine, the Autonomous University, Barcelona, Spain
Search for more papers by this authorA. Ruibal
Departments of Nuclear Medicine, the Autonomous University, Barcelona, Spain
Search for more papers by this authorR. Colomer
Departments of Radiotherapy-Oncology, Hebron Valley Hospital, the Autonomous University, Barcelona, Spain
Search for more papers by this authorM. Boada
Departments of Neurology, the Autonomous University, Barcelona, Spain
Search for more papers by this authorA. Codina
Departments of Neurology, the Autonomous University, Barcelona, Spain
Search for more papers by this authorJ. Matias-Guiu,
J. Martinez-Vazquez,
A. Ruibal,
R. Colomer,
M. Boada,
A. Codina,
Corresponding Author
J. Matias-Guiu
Departments of Neurology, the Autonomous University, Barcelona, Spain
Dr. J. Matias-Guiu, Neurology Service, Hospital del Valle de Hebrón, Barcelona SpainSearch for more papers by this authorJ. Martinez-Vazquez
Departments of Medicine, the Autonomous University, Barcelona, Spain
Search for more papers by this authorA. Ruibal
Departments of Nuclear Medicine, the Autonomous University, Barcelona, Spain
Search for more papers by this authorR. Colomer
Departments of Radiotherapy-Oncology, Hebron Valley Hospital, the Autonomous University, Barcelona, Spain
Search for more papers by this authorM. Boada
Departments of Neurology, the Autonomous University, Barcelona, Spain
Search for more papers by this authorA. Codina
Departments of Neurology, the Autonomous University, Barcelona, Spain
Search for more papers by this authorAbstract
ABSTRACT In patients with intracranial tumors (ICT) and acute cerebral infarctions (CI), both necrosis and reversible changes occur in central nervous system (CNS) tissue. The damaged CNS cells release specific substances into the cerebrospinal fluid (CFS). Radioimmunoassay (RIA)-determined myelin basic protein (MBP) and RIA-determined creatin kinase BB (CK-BB) are markers of damage to CNS specific structures. The elevated CSF level of MBP is considered a marker of myelin damage and the increased concentration of CSF CK-BB may be of combined neuronal and astrocytic origin. CSF was collected from 57 patients with the diagnosis of CI (n =30) and ICT (n =27) and the concentration of MBP and CK-BB were measured by RIA. Our study shows increased CSF levels of MBP and CK-BB in patients with CI and patients with ICT. We have also found a linear correlation between MBP and CK-BB in both CI and ICT, and for a given CK-BB level, MBP was significantly higher in patients with ICT than in patients with CI. These facts suggest that lesion markers behave differently in the different pathologic processes affecting the CNS.
References
- 1 Strand T, Alling C, Karlsson B. Winblad B. Brain and plasma proteins in spinal fluid as markers for brain damage and severity of stroke. Stroke 1984: 15: 138–144.
- 2 Herschkowitz N, Cumings N. Creatine kinase in cerebrospinal fluid. J Neurol Neurosurg Psychiatry. 1964: 27: 247–250.
- 3 Lisak RP, Craig FA. Lack of diagnostic value of creatin phosphoskinase assay in spinal fluid. JAMA 1967: 199: 750–751.
- 4 Nathan MJ. Creatin phosphokinase in the cerebrospinal fluid. J.Neurol Neurosurg Psychiatry. 1967: 30: 52–55.
- 5 Dubo H, Park DC, Pennington RJ, et al. Serum creatinkinase in cases of stroke, head injury and meningitis. Lancet 1967: 2: 743–748.
- 6 Wolintz AH, Jacobs LD, Christoff N, Salomon M, Chernik N. Serum and cerebrospinal fluid enzymes in cerebrovascular diseases. Arch Neurol 1969: 20: 54–61.
- 7 Sherwin AL, Norris JW, Bukke JA. Spinal fluid creatin kinase in neurologic disease. Neurol 1969: 19: 993–999.
- 8 Viallard JL, Gaulme J, Balens B, Dastugne B. Cerebrospinal fluid enzymology: creatine kinase, lactate deshidrogenase activity and isoenzyme pattern as a brain damage index. Clin Chim Acta 1978: 89: 405–409.
- 9 Ronquist G, Frithz G. Adenylate kinase activity and glutalthione concentration of cerebrospinal fluid in different neurological disorders. Eur Neurol 1979: 18: 106–110.
- 10 Terent A, Ronquist G. Cerebrospinal fluid markers of disturbed brain metabolism in patients with stroke and global cerebral ischemia. Acta Neurol Scand 1980: 62: 327–335.
- 11 Royds JA, Davies-Jones CAB, Lewtas NA, et al. Enolase isoenzymes in the cerbrospinal fluid of patients with diseases and the nervous system. J Neurol Neurosurg Psychiatry 1983: 43: 1031–1036.
- 12 Hay E, Royds JA, Davies-Jones AB, et al. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry 1984: 47: 724–729.
- 13 Cohen SR, Herndon RH, Mc Khann GM. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. New Engl J Med 1976: 295: 1455–1457.
- 14 Whitaker JN, Lisak RP, Bashir RM, et al. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann Neurol 1980: 7: 58–64.
- 15 Cohen SR, Brooks BR, Herndon RM. A diagnostic index of active demyelination. Myelin basic protein in cerebrospinal fluid. Ann Neurol 1980: 8: 25–31.
- 16 Biber A, Englert D, Dommasch D, Hempel K. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J Neurol 1981: 225: 321–236.
- 17 Warren KG, Latz I, Mc Pherson A. CSF Myelin basic protein levels in acute optic neuritis and multiple sclerosis. Can J Neurol Sci 1983: 10: 235–238.
- 18 Matias-Guiu J, Ruibal A, Buenaventura I, et al. Proteina mielinica basica en el LCR en el diagnostico de la esclerosis multiple. Arch Neurobiol 1984: 47: 259–260.
- 19 Alling C, Karlsson B, Vallfors B. Increase in myelin basic protein in CSF after brain surregery. J. Neurol 1980: 223: 225–230.
- 20 Palfreyman JW, Thomas DG. Ratcliffe JG Radioimmunoassay of human myelin basic protein in tissue extract, CSF and serum, and its clinical application to patients with head injury. Clin Chim Acta 1978: 82: 259–170.
- 21 Sutton LW, Wood JH, Brooks BR, et al. Cerebrospinal fluid myelin basic protein in hydrocephalus. J Neurosurg 1983: 59: 467–470.
- 22 Thompson RJ, Kynoch PAM, Sarjant J. Immunohistochemical localization of creatinkinase BB isoenzyme to astrocytes in human brain. Brain Res 1980: 201: 423–426.
- 23 Yoshimine T, Morimoto K, Homburger HA. Immunohisto-chemical localization of creatinkinase BB-isoenzyme in human brain. Compariscn with tubulin and astroprotein. Brain Res 1983: 265: 101–108.
- 24
Lang H.
Creatine kinase Isoenzymes. In:Pathophysiology and clinical application. Springer-Verlag: Berlin, 1981.
10.1007/978-3-642-68041-0 Google Scholar
- 25 Lederer WH, Gerstbrein HL. Creatin kinase isoenzyme BB activity in serum of a patient with gastric cancer. Clin Chem 1976: 22: 1748–1749.
- 26 Coolen RB. The production of brain type creatinkinase BB in the serum of patients with oat cell carcinoma. Clin Chem 1976: 22: 1174.
- 27 Hoag GN, Amies DR. Occurrence of creatinkinase BB isoenzyme in serum of a patient with prostate carcinoma and in tumor homogenates. Clin Biochem 1978: 2: 38–41.
- 28 Hoag GN, Frank CR, de Coteau WE. Creatine kinase isoenzymes in serum of patients with cancer of varios organs. Clin Chem 1978: 24: 1654.
- 29 Silverman LM, Dermer GB, Zweig MH, et al. Creatine kinase BB: a new tumor associate marker. Clin Chem 1979: 25: 1432–1435.
- 30 Zweig MH, Silverman LM, Dermer GB, van Steirteghem AC. Serum creatine kinase isoenzyme BB as an indicator of active metastasic disease. Clin Chem 1979: 25: 1190–91.
- 31
Coolen RB,
Pragay DA,
Nosanchuk JS,
Belding R.
Elevation of brain type creatine kinase in serum from patients with carcinoma.
Cancer
1979: 44: 1414–18.
10.1002/1097-0142(197910)44:4<1414::AID-CNCR2820440436>3.0.CO;2-S CAS PubMed Web of Science® Google Scholar
- 32 Feld RD, van Steirteghem AC, Zweig MH, et al. The presence of creatinkinase BB isoenzymes in patients with prostatic cancer. Clin Chim Acta 1980: 100: 267–273.
- 33 Homburger HA, Miler SA, Jacob GL. Radioimmunoassay of creatinkinase B isoenzymes in serum of patients with azotemia, obstructive uropathy or carcinoma of the prostate or bladder. Clin Chem 1980: 26: 1821–1824.
- 34 Thompson RJ, Rubery ED, Jones HM. Radioimmunoassay og serum creatine kinase BB as a tumor marker in breast cancer. Lancet 1980: 2: 673–675.
- 35 Burlina A, Plebani H, Rizzotti P. Creatinkinase isoenzyme BB: a marker of gastric cancer. Clin Chem 1983: 29: 390–1.
- 36 Kaste M, Sommer M, Kontinen A. Brain type creatinkinase isoenzyme. Ocurrence in serum in acute cerebral disorders. Arch Neurol 1977: 34: 142–144.
- 37 Philips JP, Jones HM, Hitchcock R, Adams R. Radioimmunoassay of serum creatinkinase BB as index of brain damage after head injury. Br Med J 1980: 1: 777–779.
- 38 Kaste M, Hernesnieni S, Somer H. Creatinkinase isoenzymes in acute brain injury. J Neurosurg 1981: 55: 511–515.
- 39 Hans P, Burn JD, Chopelle JP, Milbow G. Creatinkinase isoenzymes in severe head injury. J Neurosurg 1983: 58: 689–692.
- 40 Pfeiffer FE, Homburger HA, Yanagihara T. Creatin kinase BB isoenzyme in cerebral fluid in neurological disease. Measurement by radioimmunoassay. Arch Neurol 1983: 40: 169–172.
- 41 Matias-Guiu J, Martinez-Vazquez JM, Ruibal A, Codina A. Cerebrospinal fluid levels of myelin basic protein and creatinkinase BB as index of active demyelination. Acta Neurol Scand (in press).
- 42 Palfreyman JW, Johnston RV, Ratcliffe JG, et al. Radioimmunoassay of serum myelin basic protein and its application to patients with cerebrovascular accident. Clin Chim Acta 1979: 92: 403–409.
- 43 Seeldrayers PA, Hoyle NR, Thomas DGT. Serum MBP immunoreactivity and immunoglobulin level as marker of tumor type. J Neurooncol 1984: 2: 141–145.
- 44 Vaagenes P, Kjekshus J, Torvik A. The relationship between cerebrospinal fluid creatinekinase and morphological changes in the brain after transient cardiac arrest. Circul 1980: 61: 1194–1199.
- 45 Pfeiffer FE, Homburger HA, Yanahiara T. Serum creatinkinase B concentrations in acute cerebrovascular diseases. Arch Neurol 1984: 41: 1175–1178.
- 46 Sindic CJH, Chalon MP, Cambiaso CL, et al. Assessment of damage to the central nervous system by determination of S-100 protein in cerebrospinal fluid. J. Neurol Neurosurg Psychiatry 1982: 45: 1130–1135.
- 47 Hayakawa T, Ushio Y, Mori T, et al. Levels in stroke patients of CSF astroprotein, an astrocyte-specific cerebroprotein. Stroke 1979: 10: 685–689.
- 48 Schmechel D, Marangos P, Zis AP, et al. Brain enolases as specific markers of neuronal and glial cells. Science 1978: 199: 313–315.
- 49 Royds JA, Timperley WR, Taylor CB. Levels of enolase and other enzymes in the cerebrospinal fluid as indices of pathological changes. J Neurol Neurosug Psychiatry 1981: 44: 1129–1135.
- 50 Ludwin SK. Pathology af demyelination and remyelination. In: Demyelinating diseases: basic and clinical electrophisiology. Eds SG Waxman, JM. Ritchie Raven Press New York, 1981: 123–168.
